# Pfizer Inc. (NYSE: PFE), New York, NY – FDA Inspections

Source: https://www.keypedia.com/companies/pfizer-inc/76ccbd36-adc6-4041-a66b-2726d323f628

> Inspection records and compliance data for Pfizer Inc. in New York, New York. 5 FDA inspections on record (1 OAI), last inspected July 22, 2022. Publicly traded as NYSE: PFE.

---

## Details

- Name: Pfizer Inc.
- FEI Number: 2416101
- Address Line 1: 235 East 42nd Street
- City: New York
- State: New York
- Zip Code: 10017
- Country Name: United States
- Address: 235 East 42nd Street, New York, New York 10017, United States
- Country: United States

## Stock

- Stock ticker: PFE
- Exchange: NYSE
- Share price: $29.91
- Market cap: $170.5B
- Price as of: November 6, 2026

## Related Documents

- FDA Inspection 1176364 - Pfizer Inc. - 2022-07-22 — classification: No Action Indicated (NAI), source: FDA, date: July 22, 2022
- [FDA Inspection 946884 - Pfizer Inc. - 2015-08-26](https://www.keypedia.com/records/fda_inspections/pfizer-inc/db0e128d-dba7-43d8-ba7e-816e03528044) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2015
- [FDA Inspection 805292 - Pfizer Inc. - 2012-10-15](https://www.keypedia.com/records/fda_inspections/pfizer-inc/61c225de-bb74-46cc-b3fe-94bd27efa086) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 15, 2012
- FDA Inspection 805292 - Pfizer Inc. - 2012-10-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 15, 2012
- FDA Inspection 785976 - Pfizer Inc. - 2012-06-06 — classification: No Action Indicated (NAI), source: FDA, date: June 6, 2012
- [FDA Inspection 606526 - Pfizer Inc. - 2009-08-10](https://www.keypedia.com/records/fda_inspections/pfizer-inc/be0b721d-2553-4d74-aa0d-fe8c2d5d6343) — classification: Official Action Indicated (OAI), source: FDA, date: August 10, 2009
- FDA Inspection 606526 - Pfizer Inc. - 2009-08-10 — classification: Official Action Indicated (OAI), source: FDA, date: August 10, 2009

## Related Companies

- [Naveed Iqbal, M.D.](https://www.keypedia.com/companies/naveed-iqbal-md/b182c52f-fb6e-4841-a03e-76bc6a807bd7)
- [Marksans Pharmaceuticals  Ltd](https://www.keypedia.com/companies/marksans-pharmaceuticals-ltd/8c0e52f9-2d1d-4e90-814f-c4758f55ea89)
- [Miguel-Angel Perales, MD](https://www.keypedia.com/companies/miguel-angel-perales-md/ace7ffc3-fe44-4728-8019-7b5f8f62a90c)
- [Jared C. Barlow, M.D.](https://www.keypedia.com/companies/jared-c-barlow-md/37392cc0-6de0-437b-8866-c35670f09521)
- [Ellen Ritchie, MD](https://www.keypedia.com/companies/ellen-ritchie-md/82b3b4e8-cc39-4644-9bb2-b18f28e66ce1)
- [Albany College Pharmacy IRB](https://www.keypedia.com/companies/albany-college-pharmacy-irb/bc3122d3-4a0d-49d0-aee0-13b31a45a43e)
- [William M. Kufs, MD](https://www.keypedia.com/companies/william-m-kufs-md/6ced0cc5-de36-40bf-9ebc-fc05aa0d10d5)
- [Charles Marmar, M.D.](https://www.keypedia.com/companies/charles-marmar-md/5c9d4d41-5ddd-4dd1-9646-3725b0f21963)
- [Scott T. Tagawa, M.D.](https://www.keypedia.com/companies/scott-t-tagawa-md/2c3f0b86-ec04-40ff-94d3-2dd63446ea85)
- [Paula J. Busse, M.D.](https://www.keypedia.com/companies/paula-j-busse-md/42ffaa95-1f44-4f25-af1d-4c6febb7da14)